| BMD | bone mineral density |
| bALP | bone-specific alkaline phosphatase |
| β-CTX | β-collagen I carboxy terminal telopeptide |
| BO | Barrett’s esophagus |
| Ca | calcium |
| CAD | coronary artery disease |
| cagA | cytotoxin-associated gene A |
| CagA | cytotoxin associated antigen A |
| CHF | congestive heart failure |
| CKD | chronic kidney disease |
| COPD | chronic obstructive pulmonary disease |
| CVD | cardiovascular disease |
| DC | dendritic cell |
| DM | diabetes mellitus |
| GERD | gastroesophageal reflux disease |
| HRT | hormone replacement therapy |
| H.p. | Helicobacter pylori |
| HPI | Helicobacter pylori infection |
| H2RA | histamine-2 receptor antagonist |
| HR | hazard ratio |
| IL | interleukin |
| ITT | idiopathic thrombocytopenic purpura |
| Mg | magnesium |
| MALT | mucosa-associated lymphoid tissue B-cell lymphoma |
| MAFLD | metabolic associated fatty liver disease |
| OC | osteocalcin |
| OF | osteoporotic fracture |
| OP | osteoporosis |
| OPG | osteoprotegerin |
| RF | risk factor |
| P1NP | N-terminal cross-links of human procollagen type I |
| PO4 | phosphate |
| PPI | proton pump inhibitor |
| PTH | parathyroid hormone |
| PUD | peptic ulcer disease |
| RA | rheumatoid arthritis |
| RANK | receptor activator of nuclear factor κB |
| RANKL | receptor activator of nuclear factor-kappa B (NF-kB) ligand |
| TNF-α | tumor necrosis factor alpha |